Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Cirrhosis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Cirrhosis
    TopAbstracts in Cirrhosis 06/30/2009 - (DGNews)
    TopAbstracts in Cirrhosis 06/02/2009 - (DGNews)
    Primary Biliary Cirrhosis Associated with HLA, IL12A, and IL12RB2 Variants - (N Engl J Med)
    TopAbstracts in Cirrhosis 05/05/2009 - (DGNews)
    Satavaptan Reduces Ascites, Need for Paracentesis and Improves Renal Function in Patients With Advanced Cirrhosis: Presented at EASL - (DGDispatch)

    News archive

     Recent webcasts/CME - Cirrhosis

    Webcasts/CME archive

     Recent cases - Cirrhosis
      Near Fatal Posterior Reversible Encephalopathy Syndrome Complicating Chronic Liver Failure and Treated by Induced Hypothermia and Dialysis: A Case Report
      Hepatic Splenosis Mimicking HCC in a Patient with Hepatitis C Liver Cirrhosis and Mildly Raised Alpha Feto Protein; the Important Role of Explorative Laparoscopy
      Primary Biliary Cirrhosis with a Normal Alkaline Phosphatase: A Case Report
      Rare Case of Cefotaxime Induced Leukocytoclastic Vasculitis in Alcoholic Cirrhosis Patient
      Tuberculous Peritonitis in a German Patient with Primary Biliary Cirrhosis: A Case Report

      Cases archive
        




      my personal edition > cirrhosis > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Nadolol plus Spironolactone Reduces Complications in Cirrhotic Patients

      A DGReview of :"Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study."
      Hepatology

      02/06/2003
      By David Loshak


      The combined use of nadolol and spironolactone in patients with liver cirrhosis reduces the incidence of the two portal-hypertensive complications, bleeding and ascites, together.

      Adding spironolactone to nadolol, however, does not increase the efficacy of nadolol alone in preventing the first variceal bleeding, report gastroenterological specialists in Buenos Aires, Argentina.

      They pointed out that treatment with beta-blockers did not lower portal pressure in nearly 40% of cirrhotic patients. Also, recent studies had suggested that spironolactone reduced pressure and flow in the portal and variceal systems.

      The specialists, therefore, looked into whether nadolol plus spironolactone was more effective than nadolol alone in preventing the first variceal bleeding.

      In a multi-centre, double-blind, trial, the specialists randomised 100 patients with medium and large varices who had never bled and were without ascites to receive nadolol plus placebo or nadolol plus spironolactone 100 mg. daily.

      Hepatic venous pressure gradient and the activity of the renin-aldosterone system were measured in 24 of the patients.

      At a mean follow-up of 22±16 months, there were no significant differences between the two patient groups in the appearance of variceal bleeding and ascites. But, the incidence of the two complications considered together was almost twice as high (39%) in the 51 patients given nadolol plus placebo than in the 49 who received nadolol plus spironolactone (20%).

      Clinical ascites was also significantly higher in patients in the placebo group (21%) than in the spironolactone group (6%). In addition, in the spironolactone group only, the researchers observed significant increases in plasma renin activity and plasma aldosterone levels.

      The cumulative probabilities of remaining free of bleeding and ascites were similar in both groups after 70 months of follow-up.
      Hepatology 2003;37:2:359-365. "Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study."

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send